Offer to PurchaseOffer to Purchase • October 13th, 2023 • ELI LILLY & Co • Pharmaceutical preparations
Yosemite Falls Acquisition Corporation, a Delaware corporation (“Purchaser”) and a wholly-owned subsidiary of Eli Lilly and Company, an Indiana corporation (“Lilly”), is offering to purchase all of the issued and outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of POINT Biopharma Global Inc., a Delaware corporation (“POINT”), at a purchase price of $12.50 per Share (the “Offer Price”), net to the stockholder in cash, without interest and less any applicable tax withholding, upon the terms and subject to the conditions set forth in this Offer to Purchase and in the related Letter of Transmittal (which, together with this Offer to Purchase, as each may be amended or supplemented from time to time, collectively constitute the “Offer”).
CONFIDENTIALITY AGREEMENTConfidentiality Agreement • October 13th, 2023 • ELI LILLY & Co • Pharmaceutical preparations
THIS CONFIDENTIALITY AGREEMENT (the “Agreement”) is made on the last date signed below, (the “Effective Date”), between Eli Lilly and Company and its Affiliates, having its principal place of business at Lilly Corporate Center, Indianapolis, IN 46285, United States (“Lilly”), and Point Biopharma Global, Inc., having its principal place of business at 4850 West 78th St., Indianapolis, Indiana, 46268, United States.
